Showing results (71-80 of 142) with videos related to
Sort By:
Pageof 15
European Journal of Nuclear Medicine and Molecular Imaging|December 28, 2024
Evaluation of long axial field-of-view (LAFOV) PET/CT for post-treatment dosimetry in Yttrium-90 radioembolization of liver tumors: a comparative study with conventional SPECT imagingKonstantinos G Zeimpekis, Hasan Sari, Nasir Gözlügöl, et al.European Physical Journal Plus|May 16, 2023
Artificial intelligence for reducing the radiation burden of medical imaging for the diagnosis of coronavirus diseaseJiaxi Hu, Stavroula Mougiakakou, Song Xue, et al.European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2012
Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRIAli Afshar-Oromieh, Frederik L Giesel, Heinz G Linhart, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2017
Repeated PSMA-targeting radioligand therapy of metastatic prostate cancer with 131I-MIP-1095Ali Afshar-Oromieh, Uwe Haberkorn, Christian Zechmann, et al.Medical Physics|February 12, 2025
Automatic bone marrow segmentation for precise [177Lu]Lu-PSMA-617 dosimetryZhonglin Lu, Jiaxi Hu, Gefei Chen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 18, 2016
PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617Clemens Kratochwil, Frederik L Giesel, Melsa Stefanova, et al.Cancer Letters|January 20, 2022
Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancerJuening Kang, Federico La Manna, Francesco Bonollo, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2022
Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [18F]-FDG datasets from a long axial FOV PET scannerHasan Sari, Lars Eriksson, Clemens Mingels, et al.Molecules (Basel, Switzerland)|July 13, 2024
Tailoring Fibroblast-Activation Protein Targeting for Theranostics: A Comparative Preclinical Evaluation of the 68Ga- and 177Lu-Labeled Monomeric and Dimeric Fibroblast-Activation Protein Inhibitors DOTA.SA.FAPi and DOTAGA.(SA.FAPi)2Tilman Läppchen, Adrianna Bilinska, Eirinaios Pilatis, et al.Nuklearmedizin. Nuclear Medicine|July 8, 2026
Frequency and new-onset rates of nausea and fatigue in ¹⁷⁷Lu-PSMA therapy with standardized premedicationWolfram A Bosbach, Karene Sriramachandran, Nasir Gözlügöl, et al.Pageof 15